SPOTLIGHT: NZ Activists challenge Herceptin denial

Breast Cancer survivors in New Zealand won a small victory in their challenge to the government's decision not to fund a full course of Herceptin treatment; the women have won the right to see behind-the-scenes documents detailing just how the drug-buying agency made its decision. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.